MDS/AML and AML with myelodysplasia-related gene mutations: clinical and molecular similarities.
This retrospective cohort study analyzed 2,684 intensively treated adults with newly diagnosed AML, comparing: - Clinic...
Impact of fitness categorization according to SIE/SIES/GITMO criteria in therapy-related and AML-MRC receiving CPX-351.
- Post category:Hematologic Cancers
- Reading time:1 min read
Study type and population - Multicenter, real-world cohort (2019–2022) of 403 patients with AML with myelodysplasia-...
The global epidemiology of acute myeloid leukaemia.
- Post category:Hematologic Cancers
- Reading time:2 mins read
This review article examines global patterns in acute myeloid leukemia (AML), emphasizing disparities between high-incom...
Menin inhibitors as targeted therapy in KMT2A-Rearranged acute leukemia: A comprehensive review of current advances and therapeutic implications.
- Post category:Hematologic Cancers
- Reading time:2 mins read
This publication reviews the emerging role of menin inhibition as a targeted strategy for acute leukemias characterized...
Optimizing lower intensity triplet therapy in acute myeloid leukemia: a practical guide.
- Post category:Hematologic Cancers
- Reading time:1 min read
This publication reviews the emerging use of frontline triplet therapies combining venetoclax-based doublets (azacitidin...
JAK inhibitor selection in challenging scenarios of myelofibrosis: a review.
- Post category:Hematologic Cancers
- Reading time:1 min read
This publication reviews the current landscape of JAK inhibitors in the treatment of myelofibrosis, a myeloproliferative...